Pharming Group (PHAR) Institutional Ownership $10.96 -0.15 (-1.35%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$10.99 +0.03 (+0.26%) As of 08/1/2025 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Pharming Group (NASDAQ:PHAR)CurrentInstitutional OwnershipPercentage0.03%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$259.41KNumber ofInstitutional Sellers(last 12 months)0 Get PHAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Pharming Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHAR Institutional Buying and Selling by Quarter Pharming Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/9/2025 Silverberg Bernstein Capital Management LLC52,147$557K0.4%+8.6%0.077% 1/14/2025 Silverberg Bernstein Capital Management LLC47,997$483K0.4%+16.8%0.071% 10/5/2024 Silverberg Bernstein Capital Management LLC41,110$339K0.3%+75.4%0.061% 7/12/2024 Silverberg Bernstein Capital Management LLC23,435$196K0.2%+32.3%0.035% 1/17/2024 Silverberg Bernstein Capital Management LLC17,710$202K0.2%N/A0.026% 11/1/2023Orion Portfolio Solutions LLC11,715$134K0.0%N/A0.018% 2/1/2023Cowen Prime Advisors LLC21,610$238K0.1%+29.4%0.033% 2/8/2022Cowen Prime Advisors LLC14,800$132K0.0%+134.9%0.023% 8/6/2021JW Asset Management LLC169,225$1.91M0.4%-10.7%0.264% 8/4/2021Cowen Prime Advisors LLC6,300$71K0.0%N/A0.010% 5/12/2021UBS Group AG2,508$32K0.0%+173.8%0.004% (Data available from 1/1/2016 forward) PHAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHAR shares? During the previous two years, the following institutional investors and hedge funds held shares of Pharming Group shares: Silverberg Bernstein Capital Management LLC ($557K), Orion Portfolio Solutions LLC ($134K).Learn more on Pharming Group's institutional investors. What percentage of Pharming Group's stock is owned by institutional investors? 0.03% of Pharming Group's stock is owned by institutional investors. Learn more on PHAR's institutional investor holdings. Which institutional investors have been buying Pharming Group's stock? The following institutional investors have purchased Pharming Group's stock in the last 24 months: Silverberg Bernstein Capital Management LLC ($52.15K), and Orion Portfolio Solutions LLC ($11.72K). How much institutional buying is happening at Pharming Group? Institutional investors have bought a total of 28,712 shares in the last 24 months. This purchase volume represents approximately $259.41K in transactions. Related Companies OGN Institutional Ownership NAMS Institutional Ownership RXRX Institutional Ownership RARE Institutional Ownership MIRM Institutional Ownership CPRX Institutional Ownership AMRX Institutional Ownership IBRX Institutional Ownership BHC Institutional Ownership APLS Institutional Ownership This page (NASDAQ:PHAR) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group N.V. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PHAR Stock Alerts